Wegovy reviews and complaints reflect patient experiences with this FDA-approved weight-loss medication containing semaglutide. Users report significant weight reduction but also note common side effects like nausea and diarrhea.
Wegovy (semaglutide) is a GLP-1 receptor agonist that mimics natural hormones to regulate appetite and food intake. The drug slows stomach emptying, promoting feelings of fullness. Clinical trials show average weight loss of 15% over 68 weeks for participants using Wegovy alongside diet and exercise.
Most Wegovy users experience mild to moderate side effects, typically during the first few weeks of treatment. According to the FDA, the most common include:
Serious but rare risks include pancreatitis, gallbladder issues, and increased risk of thyroid tumors (observed in animal studies). Patients with a personal or family history of medullary thyroid carcinoma should avoid Wegovy.
Online forums and medical studies reveal a mix of positive outcomes and challenges. A 2022 study published in JAMA found that 85% of long-term Wegovy users maintained at least 10% weight loss after two years. However, many patients report initial struggles with side effects that improve over time.
| Experience Type | Percentage | Source |
|---|---|---|
| Significant weight loss (≥15%) | 60% | JAMA Study (2022) |
| Moderate weight loss (5-15%) | 25% | JAMA Study (2022) |
| Minimal/no weight loss | 10% | JAMA Study (2022) |
| Severe side effects requiring discontinuation | 5% | FDA Adverse Event Reporting System |
Wegovy's retail price averages $1,300 per month without insurance. Most commercial health plans cover it for patients with a BMI of 30 or higher, or 27 with obesity-related conditions. Patients often report difficulties obtaining prescriptions due to high demand and production shortages.
Wegovy competes with other GLP-1 agonists like Ozempic (also semaglutide but for diabetes) and Saxenda (liraglutide). Unlike Wegovy, Ozempic is primarily for type 2 diabetes management, though it's sometimes prescribed off-label for weight loss. Saxenda requires daily injections versus Wegovy's weekly dose.
I spoke with a patient who lost 30 pounds in six months using Wegovy but experienced persistent nausea. Their doctor adjusted the dosage, which helped mitigate the side effects while maintaining weight loss progress.